Largest Diagnostics & Research Companies by Market Cap
The Diagnostics & Research sector has 166 publicly listed stocks with a combined market cap of $902.49 Billion. Thermo Fisher Scientific Inc leads the sector with a market cap of $177.98 Billion. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$902.49 Billion
Companies Listed
166
Largest Company
Thermo Fisher Scientific …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Thermo Fisher Scientific Inc
NYSE:TMO |
$177.98 Billion | $177.98 Billion | USA | $473.72 | +0.93% | +0.19% | 53.99 Million |
| 2 |
Danaher Corporation
NYSE:DHR |
$127.92 Billion | $127.92 Billion | USA | $181.10 | +0.56% | -1.74% | 96.49 Million |
| 3 |
IDEXX Laboratories Inc
NASDAQ:IDXX |
$44.18 Billion | $44.18 Billion | USA | $570.00 | +1.63% | +1.39% | 14.73 Million |
| 4 |
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
$41.04 Billion | €35.10 Billion | Germany | €54.50 | +0.00% | -3.54% | 230.00 |
| 5 |
Agilent Technologies Inc
NYSE:A |
$36.96 Billion | $36.96 Billion | USA | $130.59 | +0.58% | -3.58% | 53.22 Million |
| 6 |
WuXi AppTec Co Ltd
SHG:603259 |
$35.96 Billion | CN¥245.77 Billion | China | CN¥99.37 | -0.34% | +2.91% | 1.03 Billion |
| 7 |
Waters Corporation
NYSE:WAT |
$34.91 Billion | $34.91 Billion | USA | $357.76 | +0.63% | -2.08% | 20.36 Million |
| 8 |
Lonza Group AG
SW:LONN |
$34.36 Billion | CHF27.18 Billion | Switzerland | CHF495.00 | +0.96% | +1.94% | 3.23 Million |
| 9 |
Natera Inc
NASDAQ:NTRA |
$30.57 Billion | $30.57 Billion | USA | $216.97 | +2.31% | +0.77% | 33.51 Million |
| 10 |
IQVIA Holdings Inc
NYSE:IQV |
$28.43 Billion | $28.43 Billion | USA | $178.39 | -1.69% | -2.76% | 34.73 Million |
| 11 |
Labcorp Holdings Inc.
MX:LH |
$22.45 Billion | MX$390.06 Billion | Mexico | MX$4705.14 | +0.00% | -4.17% | 1.93K |
| 12 |
Mettler-Toledo International Inc
NYSE:MTD |
$21.79 Billion | $21.79 Billion | USA | $1154.47 | +2.03% | +0.01% | 4.79 Million |
| 13 |
Laboratory Corporation of America Holdings
NYSE:LH |
$21.71 Billion | $21.71 Billion | USA | $265.03 | -0.42% | -0.05% | 11.77 Million |
| 14 |
Quest Diagnostics Incorporated
NYSE:DGX |
$20.74 Billion | $20.74 Billion | USA | $202.18 | -0.43% | +0.94% | 19.53 Million |
| 15 |
EXACT Sciences Corporation
NASDAQ:EXAS |
$19.80 Billion | $19.80 Billion | USA | $1819.87 | +0.25% | -2.61% | 37.42 Million |
| 16 |
Illumina Inc
NASDAQ:ILMN |
$18.34 Billion | $18.34 Billion | USA | $166.89 | +3.68% | +2.82% | 46.19 Million |
| 17 |
Medpace Holdings Inc
NASDAQ:MEDP |
$13.08 Billion | $13.08 Billion | USA | $467.50 | +0.03% | +2.92% | 6.83 Million |
| 18 |
Guardant Health Inc
NASDAQ:GH |
$12.69 Billion | $12.69 Billion | USA | $129.82 | -1.37% | +3.35% | 55.64 Million |
| 19 |
Revvity Inc.
NYSE:RVTY |
$11.22 Billion | $11.22 Billion | USA | $100.55 | +0.89% | +2.22% | 30.05 Million |
| 20 |
Eurofins Scientific SE
F:ESF0 |
$11.18 Billion | €9.56 Billion | Germany | €59.14 | +0.03% | +0.92% | 2.33K |
| 21 |
Eurofins Scientific SE
PA:ERF |
$10.22 Billion | €8.74 Billion | France | €63.38 | -1.09% | -2.37% | 7.72 Million |
| 22 |
ICON PLC
NASDAQ:ICLR |
$9.25 Billion | $9.25 Billion | USA | $147.72 | +1.05% | -1.16% | 26.09 Million |
| 23 |
Charles River Laboratories
NYSE:CRL |
$9.08 Billion | $9.08 Billion | USA | $188.47 | +0.51% | +3.93% | 18.31 Million |
| 24 |
Biomerieux SA
PA:BIM |
$8.48 Billion | €7.25 Billion | France | €67.45 | -0.44% | -7.41% | 3.90 Million |
| 25 |
WuXi AppTec Co. Ltd
F:WX8 |
$8.14 Billion | €6.97 Billion | Germany | €13.65 | -0.87% | +0.46% | 400.00 |
| 26 |
Qiagen NV
NYSE:QGEN |
$7.63 Billion | $7.63 Billion | USA | $37.01 | -0.13% | +0.90% | 51.61 Million |
| 27 |
ICON Public Limited Company
F:IJF |
$7.52 Billion | €6.43 Billion | Germany | €125.30 | -2.11% | +2.54% | 0.00 |
| 28 |
Sonic Healthcare Ltd
AU:SHL |
$6.97 Billion | AU$9.86 Billion | Australia | AU$19.94 | -1.29% | +4.62% | 40.48 Million |
| 29 |
Sotera Health Co
NASDAQ:SHC |
$4.63 Billion | $4.63 Billion | USA | $16.23 | +0.25% | +3.91% | 86.47 Million |
| 30 |
RadNet Inc
NASDAQ:RDNT |
$4.49 Billion | $4.49 Billion | USA | $57.05 | +0.60% | +4.99% | 17.24 Million |
| 31 |
Twist Bioscience Corp
NASDAQ:TWST |
$4.31 Billion | $4.31 Billion | USA | $80.79 | +6.07% | +16.71% | 40.54 Million |
| 32 |
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN |
$4.31 Billion | $4.31 Billion | USA | $103.95 | +2.80% | +6.96% | 18.04 Million |
| 33 |
Hangzhou Tigermed Consulting
SHE:300347 |
$4.25 Billion | CN¥29.07 Billion | China | CN¥39.40 | -1.05% | +1.23% | 463.63 Million |
| 34 |
Joinn Laboratories(China)Co
SHG:603127 |
$3.02 Billion | CN¥20.64 Billion | China | CN¥32.74 | +0.68% | +0.43% | 733.25 Million |
| 35 |
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
$2.92 Billion | Rs269.84 Billion | India | Rs1616.00 | +0.91% | +5.15% | 6.56 Million |
| 36 |
Veracyte Inc
NASDAQ:VCYT |
$2.83 Billion | $2.83 Billion | USA | $49.15 | +3.85% | +0.86% | 27.42 Million |
| 37 |
GRAIL, LLC
NASDAQ:GRAL |
$2.57 Billion | $2.57 Billion | USA | $59.81 | -0.07% | -0.28% | 19.21 Million |
| 38 |
BGI Genomics Co Ltd
SHE:300676 |
$2.11 Billion | CN¥14.39 Billion | China | CN¥34.40 | +0.56% | -1.49% | 154.51 Million |
| 39 |
Syngene International Limited
NSE:SYNGENE |
$1.97 Billion | Rs182.18 Billion | India | Rs453.50 | -1.10% | +4.43% | 25.27 Million |
| 40 |
Vimian Group AB
ST:VIMIAN |
$1.79 Billion | Skr16.62 Billion | Sweden | Skr31.60 | +5.33% | +12.26% | 10.40 Million |
| 41 |
Zhejiang DiAn Diagnostics Co
SHE:300244 |
$1.73 Billion | CN¥11.79 Billion | China | CN¥18.87 | -4.65% | +12.19% | 696.02 Million |
| 42 |
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
$1.68 Billion | CN¥11.48 Billion | China | CN¥24.78 | -1.98% | +3.16% | 134.76 Million |
| 43 |
Fleury S.A.
SA:FLRY3 |
$1.60 Billion | R$8.14 Billion | Brazil | R$14.98 | -1.32% | +1.56% | 54.69 Million |
| 44 |
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
$1.43 Billion | Rs132.04 Billion | India | Rs1283.20 | -0.31% | -6.50% | 6.29 Million |
| 45 |
GeneDx Holdings Corp.
NASDAQ:WGS |
$1.18 Billion | $1.18 Billion | USA | $61.32 | +2.34% | +17.45% | 30.37 Million |
| 46 |
CareDx Inc
NASDAQ:CDNA |
$1.13 Billion | $1.13 Billion | USA | $24.08 | +4.83% | +8.22% | 16.59 Million |
| 47 |
NeoGenomics Inc
NASDAQ:NEO |
$1.13 Billion | $1.13 Billion | USA | $11.09 | -0.54% | +1.74% | 33.17 Million |
| 48 |
Beijing Strong Biotechnologies Inc
SHE:300406 |
$990.08 Million | CN¥6.77 Billion | China | CN¥11.54 | +0.00% | -3.43% | 102.59 Million |
| 49 |
Amoy Diagnostics Co Ltd
SHE:300685 |
$976.86 Million | CN¥6.68 Billion | China | CN¥17.05 | +0.41% | -14.32% | 261.97 Million |
| 50 |
Shanghai Runda Med Tech Co
SHG:603108 |
$931.95 Million | CN¥6.37 Billion | China | CN¥10.55 | +0.96% | -9.67% | 733.79 Million |
| 51 |
Thyrocare Technologies Limited
NSE:THYROCARE |
$921.91 Million | Rs85.25 Billion | India | Rs535.60 | +1.27% | +3.40% | 10.93 Million |
| 52 |
Opko Health Inc
NASDAQ:OPK |
$860.81 Million | $860.81 Million | USA | $1.40 | -1.41% | -2.78% | 66.41 Million |
| 53 |
Clinica Baviera
MC:CBAV |
$842.36 Million | €720.51 Million | Spain | €56.00 | +0.00% | -5.72% | 109.61K |
| 54 |
Maccura Biotechnology Co Ltd
SHE:300463 |
$765.37 Million | CN¥5.23 Billion | China | CN¥8.65 | +1.29% | -4.84% | 160.30 Million |
| 55 |
Cowealth Medical China Co.Ltd.
SHG:603122 |
$708.29 Million | CN¥4.84 Billion | China | CN¥12.16 | +0.33% | -2.25% | 280.55 Million |
| 56 |
Diagnósticos da América S.A
SA:DASA3 |
$686.64 Million | R$3.50 Billion | Brazil | R$2.80 | -0.71% | +1.08% | 39.95 Million |
| 57 |
Castle Biosciences Inc
NASDAQ:CSTL |
$626.62 Million | $626.62 Million | USA | $20.66 | -0.19% | -1.67% | 8.80 Million |
| 58 |
Personalis Inc
NASDAQ:PSNL |
$626.23 Million | $626.23 Million | USA | $9.79 | +2.09% | -8.93% | 73.57 Million |
| 59 |
Integral Diagnostics Ltd
AU:IDX |
$546.21 Million | AU$771.96 Million | Australia | AU$2.07 | +1.47% | +1.97% | 40.60 Million |
| 60 |
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
$525.01 Million | CN¥3.59 Billion | China | CN¥15.89 | +0.19% | -2.16% | 206.95 Million |
| 61 |
Fulgent Genetics Inc
NASDAQ:FLGT |
$521.15 Million | $521.15 Million | USA | $18.35 | -1.77% | -4.18% | 11.06 Million |
| 62 |
Guangdong Hybribio Biotech Co Ltd
SHE:300639 |
$508.02 Million | CN¥3.47 Billion | China | CN¥5.37 | +0.94% | -1.10% | 418.25 Million |
| 63 |
HANGZHOU TIGERMED CO. H 1
F:5HZ1 |
$503.81 Million | €430.94 Million | Germany | €3.50 | -1.13% | +0.57% | 0.00 |
| 64 |
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
$502.27 Million | CN¥3.43 Billion | China | CN¥8.57 | -0.46% | -1.04% | 176.07 Million |
| 65 |
Lumibird SA
PA:LBIRD |
$489.86 Million | €419.00 Million | France | €23.50 | -2.08% | -5.05% | 1.04 Million |
| 66 |
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439 |
$485.33 Million | CN¥3.32 Billion | China | CN¥8.63 | +0.12% | -3.14% | 83.84 Million |
| 67 |
SMO ClinPlus Co. Ltd.
SHE:301257 |
$463.01 Million | CN¥3.16 Billion | China | CN¥40.05 | -2.20% | -3.63% | 44.42 Million |
| 68 |
Berry Genomics Co Ltd
SHE:000710 |
$415.92 Million | CN¥2.84 Billion | China | CN¥8.04 | -0.25% | -3.37% | 209.15 Million |
| 69 |
Myriad Genetics Inc
NASDAQ:MYGN |
$408.02 Million | $408.02 Million | USA | $4.32 | -0.23% | -5.47% | 40.87 Million |
| 70 |
Chemclin Diagnostics Co. Ltd. A
SHG:688468 |
$354.52 Million | CN¥2.42 Billion | China | CN¥6.04 | +0.00% | -3.36% | 80.94 Million |
| 71 |
Voxel S.A.
WAR:VOX |
$332.40 Million | zł1.21 Billion | Poland | zł115.00 | -2.21% | +1.05% | 293.33K |
| 72 |
Integrated Diagnostics Holdings PLC
LSE:IDHC |
$323.22 Million | $323.22 Million | UK | $0.56 | +4.91% | +1.09% | 8.64 Million |
| 73 |
Prenetics Global Ltd
NASDAQ:PRE |
$316.38 Million | $316.38 Million | USA | $20.75 | -4.07% | +4.48% | 7.08 Million |
| 74 |
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
$304.43 Million | CN¥2.08 Billion | China | CN¥51.92 | -0.35% | +7.38% | 25.47 Million |
| 75 |
Metropolis Healthcare Limited
NSE:METROPOLIS |
$294.79 Million | Rs27.26 Billion | India | Rs525.90 | -0.90% | -1.37% | 8.17 Million |
| 76 |
Australian Clinical Labs Ltd
AU:ACL |
$293.47 Million | AU$414.76 Million | Australia | AU$2.21 | +2.31% | +8.33% | 14.42 Million |
| 77 |
Spectral Med Inc
TO:EDT |
$290.73 Million | CA$401.90 Million | Canada | CA$1.39 | +0.72% | +0.72% | 1.21 Million |
| 78 |
INTERGRATED DIA.H DL 025
F:8I8 |
$282.73 Million | €241.83 Million | Germany | €0.42 | -0.95% | +0.00% | 0.00 |
| 79 |
Vimta Labs Limited
NSE:VIMTALABS |
$263.56 Million | Rs24.37 Billion | India | Rs546.00 | -1.60% | +0.30% | 6.86 Million |
| 80 |
Healius Ltd
AU:HLS |
$202.95 Million | AU$286.83 Million | Australia | AU$0.40 | +9.72% | +23.44% | 157.37 Million |
| 81 |
Monash Ivf Group Ltd
AU:MVF |
$194.36 Million | AU$274.69 Million | Australia | AU$0.71 | +2.92% | +1.44% | 10.49 Million |
| 82 |
Krsnaa Diagnostics Limited
NSE:KRSNAA |
$189.00 Million | Rs17.48 Billion | India | Rs538.75 | +0.83% | -2.38% | 1.89 Million |
| 83 |
Green Cross Lab Cell Corporation
KQ:144510 |
$176.38 Million | ₩260.27 Billion | Korea | ₩17320.00 | +2.91% | +0.81% | 1.15 Million |
| 84 |
Selvita S.A.
WAR:SLV |
$157.08 Million | zł570.74 Million | Poland | zł31.10 | -0.48% | +6.87% | 770.36K |
| 85 |
Prodia Widyahusada Tbk PT
JK:PRDA |
$133.49 Million | Rp2.28 Trillion | Indonesia | Rp2430.00 | -0.41% | +2.97% | 24.38 Million |
| 86 |
Access Bio Inc
KQ:950130 |
$125.38 Million | ₩185.01 Billion | Korea | ₩5260.00 | -1.31% | -0.94% | 3.72 Million |
| 87 |
Fonar Corporation
NASDAQ:FONR |
$117.84 Million | $117.84 Million | USA | $19.09 | +0.00% | +0.95% | 2.89 Million |
| 88 |
MDxHealth SA ADR
NASDAQ:MDXH |
$111.46 Million | $111.46 Million | USA | $2.17 | -4.82% | -6.06% | 5.64 Million |
| 89 |
Bionet
TWO:1784 |
$104.60 Million | NT$3.32 Billion | Taiwan | NT$66.00 | -0.60% | -1.79% | 6.28 Million |
| 90 |
Exagen Inc
NASDAQ:XGN |
$103.65 Million | $103.65 Million | USA | $4.57 | -2.14% | +6.53% | 9.85 Million |
| 91 |
JOONGANG DNM Co.Ltd
KQ:051980 |
$103.16 Million | ₩152.22 Billion | Korea | ₩1373.00 | +1.85% | +1.33% | 43.57 Million |
| 92 |
Centro de Imagem Diagnósticos S.A
SA:AALR3 |
$103.11 Million | R$525.51 Million | Brazil | R$3.45 | +4.55% | +14.24% | 1.15 Million |
| 93 |
Scope Fluidics SA
WAR:SCP |
$93.63 Million | zł340.20 Million | Poland | zł124.80 | +0.32% | +1.63% | 65.44K |
| 94 |
SCOPE FLUIDICS SA ZY-10
F:S84 |
$91.12 Million | €77.94 Million | Germany | €24.60 | -1.01% | -5.75% | 0.00 |
| 95 |
OncoCyte Corp
NASDAQ:OCX |
$90.37 Million | $90.37 Million | USA | $3.16 | -1.25% | +0.00% | 1.54 Million |
| 96 |
BioPorto
CO:BIOPOR |
$89.08 Million | Dkr569.36 Million | Denmark | Dkr1.15 | -2.54% | -11.20% | 9.70 Million |
| 97 |
Eurofins-Cerep SA
PA:ALECR |
$87.26 Million | €74.64 Million | France | €15300.00 | +0.00% | -11.56% | 18.00 |
| 98 |
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX |
$86.66 Million | $86.66 Million | USA | $5.70 | +1.60% | +8.78% | 8.00 Million |
| 99 |
Biodesix Inc
NASDAQ:BDSX |
$79.44 Million | $79.44 Million | USA | $15.60 | +3.59% | +0.91% | 1.04 Million |
| 100 |
Burning Rock Biotech Ltd
NASDAQ:BNR |
$77.21 Million | $77.21 Million | USA | $8.76 | +1.98% | -4.89% | 512.51K |
| 101 |
Cytogen Inc
KQ:217330 |
$66.13 Million | ₩97.58 Billion | Korea | ₩4230.00 | +0.83% | +4.44% | 5.95 Million |
| 102 |
Pangaea Oncology S.A.
MC:PANG |
$56.33 Million | €48.18 Million | Spain | €1.58 | +0.00% | +0.00% | 239.01K |
| 103 |
DIVA Laboratories Ltd
TWO:4153 |
$54.99 Million | NT$1.75 Billion | Taiwan | NT$29.75 | -0.50% | -5.41% | 784.12K |
| 104 |
Quantum Cyber N.V.
NASDAQ:QUCY |
$48.27 Million | $48.27 Million | USA | $2.12 | +22.54% | -3.64% | 1.06 Billion |
| 105 |
Optipharm.CO.LTD
KQ:153710 |
$46.43 Million | ₩68.51 Billion | Korea | ₩4670.00 | +0.76% | +4.36% | 547.38K |
| 106 |
P&K Skin Research Center Co. Ltd
KQ:347740 |
$38.05 Million | ₩56.15 Billion | Korea | ₩1944.00 | +0.21% | +1.51% | 2.48 Million |
| 107 |
Cryosite Ltd
AU:CTE |
$36.61 Million | AU$51.74 Million | Australia | AU$1.06 | +0.00% | +0.00% | 155.36K |
| 108 |
Precipio Inc
NASDAQ:PRPO |
$31.61 Million | $31.61 Million | USA | $22.44 | +1.54% | -4.47% | 786.12K |
| 109 |
Inoviq Ltd
AU:IIQ |
$31.38 Million | AU$44.34 Million | Australia | AU$0.32 | +0.00% | -5.97% | 2.11 Million |
| 110 |
INIFY LABORATORIES AB
F:WY60 |
$30.74 Million | €26.29 Million | Germany | €0.80 | +69.49% | +115.05% | 0.00 |
| 111 |
Genoray Co. Ltd
KQ:122310 |
$29.39 Million | ₩43.37 Billion | Korea | ₩3570.00 | +2.00% | -0.70% | 907.74K |
| 112 |
Biocartis Group NV
BR:BCART |
$27.24 Million | €23.30 Million | Belgium | €0.29 | +0.00% | +0.00% | 0.00 |
| 113 |
RHYTHM Biosciences Ltd
AU:RHY |
$26.69 Million | AU$37.72 Million | Australia | AU$0.12 | +4.55% | +4.55% | 10.65 Million |
| 114 |
INOVIQ LTD.
F:EGQ0 |
$25.34 Million | €21.67 Million | Germany | €0.17 | +1.76% | -5.46% | 0.00 |
| 115 |
Gencurix Inc
KQ:229000 |
$22.72 Million | ₩33.53 Billion | Korea | ₩2080.00 | +2.21% | -17.13% | 41.93 Million |
| 116 |
NanoRepro AG
XETRA:NN6 |
$22.45 Million | €19.20 Million | Germany | €1.84 | +3.67% | +3.09% | 400.84K |
| 117 |
GeneMatrix Inc
KQ:109820 |
$22.42 Million | ₩33.08 Billion | Korea | ₩1657.00 | +1.47% | +0.36% | 4.33 Million |
| 118 |
Microba Life Sciences Ltd
AU:MAP |
$19.82 Million | AU$28.01 Million | Australia | AU$0.05 | +0.00% | -26.98% | 7.74 Million |
| 119 |
SenzaGen AB
ST:SENZA |
$18.29 Million | Skr169.94 Million | Sweden | Skr5.76 | -0.69% | +2.13% | 495.80K |
| 120 |
Diagnos Laboratorium Utama PT Tbk
JK:DGNS |
$18.02 Million | Rp307.50 Billion | Indonesia | Rp246.00 | +8.85% | +11.82% | 71.66 Million |
| 121 |
Bcal Diagnostics Ltd
AU:BDX |
$18.00 Million | AU$25.44 Million | Australia | AU$0.07 | -1.43% | -6.76% | 2.32 Million |
| 122 |
Enzo Biochem Inc
NYSE:ENZ |
$16.44 Million | $16.44 Million | USA | $0.54 | -0.02% | +0.00% | 135.69K |
| 123 |
Immunovia publ AB
ST:IMMNOV |
$14.91 Million | Skr138.57 Million | Sweden | Skr0.21 | +14.70% | +10.04% | 95.19 Million |
| 124 |
AroCell AB
ST:AROC |
$13.39 Million | Skr124.39 Million | Sweden | Skr0.54 | +1.12% | +4.25% | 2.49 Million |
| 125 |
NSN Co. Ltd
KQ:031860 |
$12.68 Million | ₩18.71 Billion | Korea | ₩693.00 | +17.26% | +15.69% | 50.75 Million |
| 126 |
Predilife
PA:ALPRE |
$11.91 Million | €10.19 Million | France | €2.60 | +0.00% | +0.00% | 20.81K |
| 127 |
IZOTROPIC CORP.
F:1R3 |
$11.29 Million | €9.66 Million | Germany | €0.14 | +10.24% | -4.11% | 0.00 |
| 128 |
Biomaxima
WAR:BMX |
$11.17 Million | zł40.59 Million | Poland | zł9.68 | +1.89% | +0.73% | 139.82K |
| 129 |
Genetic Signatures Ltd
AU:GSS |
$10.61 Million | AU$14.99 Million | Australia | AU$0.07 | -10.81% | -5.71% | 10.43 Million |
| 130 |
Check-Cap Ltd.
NASDAQ:MBAI |
$10.59 Million | $10.59 Million | USA | $1.44 | +3.60% | +4.35% | 3.40 Million |
| 131 |
Malaysian Genomics Resource
KLSE:0155 |
$10.23 Million | RM40.75 Million | Malaysia | RM0.27 | +1.89% | +8.00% | 4.39 Million |
| 132 |
XWELL Inc.
NASDAQ:XWEL |
$9.67 Million | $9.67 Million | USA | $1.22 | +0.83% | -10.29% | 2.78 Million |
| 133 |
Mainz Biomed BV
NASDAQ:MYNZ |
$9.49 Million | $9.49 Million | USA | $0.76 | -10.15% | -16.66% | 18.17 Million |
| 134 |
Check Cap Ltd
NASDAQ:CHEK |
$9.42 Million | $9.42 Million | USA | $139.00 | +0.72% | -2.80% | 22.52 Million |
| 135 |
Check-Cap Ltd
F:7CC |
$8.64 Million | €7.39 Million | Germany | €1.17 | +2.63% | -6.40% | 0.00 |
| 136 |
ENDRA Life Sciences Inc
NASDAQ:NDRA |
$8.16 Million | $8.16 Million | USA | $4.85 | +6.36% | +14.66% | 441.82K |
| 137 |
GENINCODE PLC LS -01
F:9PL |
$6.78 Million | €5.80 Million | Germany | €0.01 | +0.00% | -20.00% | 0.00 |
| 138 |
bioAffinity Technologies, Inc.
NASDAQ:BIAF |
$6.16 Million | $6.16 Million | USA | $1.37 | -7.43% | -20.81% | 4.68 Million |
| 139 |
Advanced Biomed Inc. Common Stock
NASDAQ:ADVB |
$6.13 Million | $6.13 Million | USA | $4.40 | -2.22% | +5.52% | 863.29K |
| 140 |
Imagion Biosystems Ltd
AU:IBX |
$5.55 Million | AU$7.85 Million | Australia | AU$0.02 | +0.00% | -11.11% | 97.06 Million |
| 141 |
iSpecimen Inc
NASDAQ:ISPC |
$4.07 Million | $4.07 Million | USA | $2.83 | +2.91% | -6.29% | 5.17 Million |
| 142 |
Telo Genomics Corp
V:TELO |
$4.02 Million | CA$5.55 Million | Canada | CA$0.07 | +0.00% | +18.18% | 1.66 Million |
| 143 |
Genetic Technologies Ltd
AU:GTG |
$4.01 Million | AU$5.67 Million | Australia | AU$0.04 | +0.00% | +0.00% | 0.00 |
| 144 |
Applied DNA Sciences Inc
NASDAQ:APDN |
$3.99 Million | $3.99 Million | USA | $3.09 | +3.00% | +24.10% | 1.14 Million |
| 145 |
Euroespes S.A.
MC:EEP |
$3.95 Million | €3.38 Million | Spain | €0.34 | +0.00% | +0.00% | 0.00 |
| 146 |
Leveljump Healthcare Corp
V:JUMP |
$3.84 Million | CA$5.31 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 147 |
Genetic Technologies Ltd
NASDAQ:GENE |
$3.71 Million | $3.71 Million | USA | $1937.10 | -0.15% | +1.28% | 9.75K |
| 148 |
Avricore Health Inc
V:AVCR |
$3.66 Million | CA$5.06 Million | Canada | CA$0.05 | -9.09% | -16.67% | 785.53K |
| 149 |
Prostatype Genomics AB
ST:PROGEN |
$3.63 Million | Skr33.74 Million | Sweden | Skr0.57 | +21.28% | +5.56% | 5.44 Million |
| 150 |
StageZero Life Sciences Ltd
TO:SZLS |
$3.58 Million | CA$4.94 Million | Canada | CA$0.04 | +0.00% | +0.00% | 0.00 |
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries